Trials / Terminated
TerminatedNCT05142904
Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
Ultrasound-guided Radiofrequency Ablation Versus Radioactive Iodine as Treatment for Hyperthyroidism Caused by Solitary Autonomous Thyroid Nodules
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Rijnstate Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare treatment of hyperthyroidism with radiofrequency ablation or I-131 for solitary autonomous thyroid nodules.
Conditions
- Thyroid Nodule, Toxic or With Hyperthyroidism
- Autonomous Thyroid Function
- Thyroid Nodule; Hyperthyroidism
- Radiofrequency Ablation
- Iodine Hyperthyroidism
- Iodine Adverse Reaction
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiofrequency ablation | Ultrasound-guided radiofrequency ablation of the solitary autonomous thyroid nodule. |
| DRUG | Radioactive iodine | I-131 according to standardized doses-calculation. |
| DRUG | Radioactive iodine | I-131 according to local standard. |
Timeline
- Start date
- 2021-11-17
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
- First posted
- 2021-12-03
- Last updated
- 2025-07-17
Locations
14 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05142904. Inclusion in this directory is not an endorsement.